Ac1-Pakpathway, and on secretion of an autocrine EGF receptor ligand.

Ac1-Pakpathway, and on secretion of an autocrine EGF receptor ligand. These studies support the existence of feed-forward loops in which Vav1 regulates secretion of autocrine ligands, leading to receptorFigure 7. Vav1 pro-apoptotic effect in MCF-7 cells. (A) MCF-7Vector and MCF-7Vav1 were stained for detection of c-H2AX foci. Three representative photographs of the foci from different areas are presented. (B) TUNEL assay of MCF-7Vector, MCF-7Vav1 cells was performed. Three representative photographs of cells from different areas are presented. doi:10.1371/journal.pone.0054321.gVav1 in Breast CancerFigure 8. The pro-apoptotic effect of Vav1 on MCF-7 cells is p53-dependant. (A) p53 is silenced in MCF-7Vav1 cells following treatment with p53 shRNA. Cells were infected with viral vectors containing shRNA for p53 (shp53) or control (pLKO). Cell lysates were subjected to immunoblotting with anti-p53 antibody. Anti-actin was used as loading control. (B) Real Time PCR analysis of selected apoptosis-related genes. The analysis was performed on the following cells: MCF-7Vector or MCF-7Vav1 infected with control viral vector and MCF-7Vav1 infected with shp53. (C) TUNEL assay of MCF-7Vav1 infected with pLKO or shp53 was performed. Three representative photographs of the cells from different areas are presented. (D) MCF-7Vav1 infected with pLKO or shp53 were suspended in RPMI medium containing 0.3 agar and 10 calf serum, and plated onto a bottom layer containing 0.8 agar. Cells were plated in triplicates, at a density of 16105/well in a 6-well plate, and colonies were photographed 14 days later. Three independent MedChemExpress Taselisib GDC-0084 site experiments were analyzed, and representative photographs of cells from different areas are presented. doi:10.1371/journal.pone.0054321.gVav1 in Breast Cancerstimulation and subsequent increases in Vav1 activation. The additional stimulatory input provided by Vav1 signaling in cells where it is aberrantly expressed may overwhelm control mechanisms and tip the scales in favor of transformation. Our soft agar and MTT assays showed opposing phenotypes of AU565 and MCF-7 cells ectopically expressing Vav1. In AU565Vav1 cells we observed an increase in foci number and size, indicative of a higher proliferation rate in comparison to AU565Vector cells. We observed the opposite in MCF-7Vav1 cells, which formed smaller foci than MCF-7Vector cells. These surprising results raised the possibility that the expression of Vav1 affects gene expression in a different manner in these cell lines. Indeed, Vav1 leads to an increase in expression of pro-proliferation genes in AU565, while pro-apoptosis genes are elevated in MCF-7 cells. The anti-apoptotic effect of Vav1 has been shown in cancers of hematopoietic origin. In vitro knockdown of Vav1 in anaplastic large cell lymphoma was sufficient to cause cell cycle arrest and apoptosis of these cells [46]. In the HL-60 and NB4 promyelocytic cell lines, down-regulation of Vav1 affected expression of a number of cell cycle/apoptosis-related proteins [47]. Lastly, Vav1 was found to protect Jurkat T cells from Fas-mediated apoptosis by promoting Bcl-2 transcription through its GEF activity toward Rac2 [48]. Other studies have pointed to a pro-apoptotic role for Vav1 in hematopoietic cells. For instance, during negative selection, Vav1 promotes antigen-induced thymocyte apoptosis, and inhibitors of the actin cytoskeleton or protein kinase C (PKC) reverse the effect [49]. In activated CD4+ T cells, the Vav1-Rac path.Ac1-Pakpathway, and on secretion of an autocrine EGF receptor ligand. These studies support the existence of feed-forward loops in which Vav1 regulates secretion of autocrine ligands, leading to receptorFigure 7. Vav1 pro-apoptotic effect in MCF-7 cells. (A) MCF-7Vector and MCF-7Vav1 were stained for detection of c-H2AX foci. Three representative photographs of the foci from different areas are presented. (B) TUNEL assay of MCF-7Vector, MCF-7Vav1 cells was performed. Three representative photographs of cells from different areas are presented. doi:10.1371/journal.pone.0054321.gVav1 in Breast CancerFigure 8. The pro-apoptotic effect of Vav1 on MCF-7 cells is p53-dependant. (A) p53 is silenced in MCF-7Vav1 cells following treatment with p53 shRNA. Cells were infected with viral vectors containing shRNA for p53 (shp53) or control (pLKO). Cell lysates were subjected to immunoblotting with anti-p53 antibody. Anti-actin was used as loading control. (B) Real Time PCR analysis of selected apoptosis-related genes. The analysis was performed on the following cells: MCF-7Vector or MCF-7Vav1 infected with control viral vector and MCF-7Vav1 infected with shp53. (C) TUNEL assay of MCF-7Vav1 infected with pLKO or shp53 was performed. Three representative photographs of the cells from different areas are presented. (D) MCF-7Vav1 infected with pLKO or shp53 were suspended in RPMI medium containing 0.3 agar and 10 calf serum, and plated onto a bottom layer containing 0.8 agar. Cells were plated in triplicates, at a density of 16105/well in a 6-well plate, and colonies were photographed 14 days later. Three independent experiments were analyzed, and representative photographs of cells from different areas are presented. doi:10.1371/journal.pone.0054321.gVav1 in Breast Cancerstimulation and subsequent increases in Vav1 activation. The additional stimulatory input provided by Vav1 signaling in cells where it is aberrantly expressed may overwhelm control mechanisms and tip the scales in favor of transformation. Our soft agar and MTT assays showed opposing phenotypes of AU565 and MCF-7 cells ectopically expressing Vav1. In AU565Vav1 cells we observed an increase in foci number and size, indicative of a higher proliferation rate in comparison to AU565Vector cells. We observed the opposite in MCF-7Vav1 cells, which formed smaller foci than MCF-7Vector cells. These surprising results raised the possibility that the expression of Vav1 affects gene expression in a different manner in these cell lines. Indeed, Vav1 leads to an increase in expression of pro-proliferation genes in AU565, while pro-apoptosis genes are elevated in MCF-7 cells. The anti-apoptotic effect of Vav1 has been shown in cancers of hematopoietic origin. In vitro knockdown of Vav1 in anaplastic large cell lymphoma was sufficient to cause cell cycle arrest and apoptosis of these cells [46]. In the HL-60 and NB4 promyelocytic cell lines, down-regulation of Vav1 affected expression of a number of cell cycle/apoptosis-related proteins [47]. Lastly, Vav1 was found to protect Jurkat T cells from Fas-mediated apoptosis by promoting Bcl-2 transcription through its GEF activity toward Rac2 [48]. Other studies have pointed to a pro-apoptotic role for Vav1 in hematopoietic cells. For instance, during negative selection, Vav1 promotes antigen-induced thymocyte apoptosis, and inhibitors of the actin cytoskeleton or protein kinase C (PKC) reverse the effect [49]. In activated CD4+ T cells, the Vav1-Rac path.